What Vitamins Are Recommended for Macular Degeneration?

What Vitamins Are Recommended for Macular Degeneration?

For most people with age-related macular degeneration, the only vitamin formulation with strong clinical evidence is the AREDS2 supplement, which contains high doses of vitamin C, vitamin E, zinc, copper, lutein, and zeaxanthin.(1–4) These supplements are recommended only for patients with intermediate AMD or advanced AMD in one eye, to reduce the risk of progression to late disease, and are not proven to prevent AMD in people without significant macular changes.(1–4)

Key Facts at a Glance

• The Age-Related Eye Disease Studies (AREDS and AREDS2) showed that specific high‑dose vitamin/mineral combinations can reduce progression from intermediate to advanced AMD.(1–3)
• The current standard is the AREDS2 formula: vitamin C 500 mg, vitamin E 400 IU, zinc 80 mg (or 25–80 mg), copper 2 mg, lutein 10 mg, and zeaxanthin 2 mg per day.(1,2,4,5)
• AREDS2 supplements are recommended for people with intermediate AMD in one or both eyes, or advanced AMD in one eye, not for those with early or no AMD.(1–3,6–8)
• High-dose eye vitamins do not cure AMD or restore lost vision, and have no proven benefit for preventing AMD in otherwise healthy individuals.(3,6–9)
• β‑carotene from the original AREDS formula is no longer recommended because it increased lung cancer risk in smokers; lutein + zeaxanthin replaced β‑carotene in AREDS2.(2,3,10)
• Any supplementation should be discussed with an eye‑care professional because high doses of some micronutrients can interact with medications or be unsafe in specific conditions.(3,8,9,11)

Pathophysiology and Rationale for Vitamin Use

Oxidative stress, chronic inflammation, and impaired handling of lipids and waste products are central to AMD pathogenesis.(3,10,12) The macula is rich in polyunsaturated fatty acids and exposed to lifelong light, making it especially vulnerable to oxidative damage. Antioxidant vitamins and carotenoids may help neutralize reactive oxygen species and stabilize cell membranes in the retinal pigment epithelium (RPE) and photoreceptors.(10,12)

Lutein and zeaxanthin are dietary carotenoids that concentrate in the macula as macular pigment, where they filter short‑wavelength blue light and act as antioxidants.(2,10,12,13) Zinc is a cofactor for numerous retinal enzymes and may support RPE function, while copper is included to prevent copper deficiency anaemia that can result from high‑dose zinc supplementation.(2,4,10) The AREDS and AREDS2 trials were designed to test whether high doses of these nutrients could slow AMD progression in people at substantial risk.

The AREDS and AREDS2 Formulations

The original AREDS trial tested a combination of vitamin C 500 mg, vitamin E 400 IU, β‑carotene 15 mg, zinc 80 mg (as zinc oxide), and copper 2 mg (cupric oxide).(1,3) In participants with intermediate AMD or advanced AMD in one eye (AREDS categories 3 and 4), this formulation reduced the 5‑year risk of progression to advanced AMD by about 25% and the risk of moderate vision loss by about 19%.(1,3,6,7) There was no significant benefit for participants with early or no AMD.(1,3,6–9)

Because β‑carotene was associated with increased lung cancer risk in smokers in other large trials, the follow‑up AREDS2 study tested updated formulations that replaced β‑carotene with lutein 10 mg and zeaxanthin 2 mg and evaluated the addition of omega‑3 fatty acids.(2,10,14) AREDS2 showed that removing β‑carotene and adding lutein/zeaxanthin maintained or slightly improved the protective effect against AMD progression, and confirmed no benefit from adding omega‑3 supplements.(2,10,14)

Based on these results, the AREDS2 formula is now considered the evidence‑based standard for AMD supplementation and is widely recommended in clinical guidelines.(1–4,10)

Who Should Take AREDS2 Supplements?

According to the National Eye Institute and expert groups, AREDS2 supplements are appropriate for:(1–3,6–8)

• People with intermediate AMD in one or both eyes (for example large drusen and/or pigment changes).
• People with advanced AMD in one eye but less advanced disease in the fellow eye.

AREDS2 supplements are not recommended for:

• Individuals without AMD or with only small drusen (early AMD), because trials showed no meaningful preventive benefit in these groups.(1,3,6–9)
• Use as treatment for neovascular (wet) AMD or central geographic atrophy; they can be used alongside other treatments but do not replace anti‑VEGF injections or other therapies.(3,6–9)

Clinical reviews emphasize that not all patients with early AMD or minimal changes should be placed on high‑dose vitamins, because the absolute risk reduction in these groups is small and potential adverse effects must be considered.(8,9,11)

Safety Considerations and Interactions

High-dose nutritional supplements can have side effects:

• β‑carotene is avoided in AREDS2 because it increased lung cancer risk in current and former smokers in multiple large trials.(2,3,10,14)
• High‑dose vitamin E has been linked in some meta-analyses to increased risk of haemorrhagic stroke or prostate cancer, although data are mixed.(11)
• Zinc 80 mg/day can cause gastrointestinal upset and may lead to copper deficiency, which is why 2 mg of copper is included; some clinicians prefer lower‑dose zinc (25–40 mg) formulations for tolerability.(4,5,10,11)

Patients taking anticoagulants, those with kidney disease, or those on other high‑dose vitamin regimens should discuss eye vitamins with their ophthalmologist and primary‑care physician to avoid harmful interactions.(8,9,11) Most sources consider it safe to combine a standard multivitamin with AREDS2 but caution against stacking multiple high‑dose products.(3,4,8,9)

Role of Diet and Lifestyle Alongside Vitamins

AREDS2 supplements are only one part of AMD management. Observational studies and secondary analyses suggest that adherence to a Mediterranean-style diet rich in leafy greens, fruits, whole grains, and fish is associated with lower risk of progression from early to late AMD, independent of supplement use.(10,13,15) Smoking cessation, blood pressure control, and regular physical activity also contribute to risk reduction.(3,10,13,15)

Eye vitamins should therefore be framed as an adjunct to, not a substitute for, healthy lifestyle, and patients should be counseled that supplements cannot undo the damage caused by smoking or poor diet.

When to Discuss Vitamins with a Specialist

You should talk to an optometrist or ophthalmologist about AREDS2 supplements if you:

• Have been diagnosed with intermediate AMD or advanced AMD in one eye.
• Have a strong family history of AMD and are unsure about your current stage.
• Are already taking multiple supplements and want to avoid overdosing on specific nutrients.

Your eye‑care provider will examine your retinas, categorize your AMD stage, and advise whether an AREDS2‑type supplement is appropriate, which brand or formulation aligns with the clinical evidence, and how to integrate it safely with your overall health regimen.(1–4,8–10)

Summary

The only vitamin regimen with robust evidence for age-related macular degeneration is the AREDS2 formulation, containing high doses of vitamin C, vitamin E, zinc, copper, lutein, and zeaxanthin. Clinical trials show that this combination reduces the risk of progression from intermediate to advanced AMD in appropriately selected patients but does not prevent AMD in healthy eyes or cure established late disease. Supplements must be targeted to those with sufficient baseline risk, and potential side effects and interactions should be considered. A nutrient‑dense diet, smoking cessation, cardiovascular risk control, and regular eye examinations remain essential pillars of AMD management alongside any use of eye vitamins.

FAQs

Do I need AREDS2 vitamins if I only have early AMD?
Probably not. AREDS/AREDS2 trials found no significant benefit of high‑dose supplements in people with small drusen or no AMD; benefits were confined to those with intermediate disease or advanced AMD in one eye.(1,3,6–9)

Can I just eat a healthy diet instead of taking AREDS2?
A Mediterranean‑style diet is strongly recommended and linked to lower AMD progression risk, but the specific high doses in AREDS2 are difficult to achieve from food alone.(2,4,10,13,15) For eligible patients, diet and supplements are complementary, not interchangeable.

Are eye vitamins helpful for wet AMD?
AREDS2 supplements do not treat active neovascular AMD and cannot replace anti‑VEGF injections.(3,6–9) They may still be recommended to protect the fellow eye or slow dry components, depending on stage.

Is it safe to take AREDS2 if I smoke?
AREDS2 formulations without β‑carotene were designed to be safer for current and former smokers.(2,3,10) However, smokers should discuss any high‑dose supplements with their clinicians, and quitting smoking remains the most important step to reduce AMD risk.(3,10,13,15)

Can I take AREDS2 together with my multivitamin?
Most guidance suggests it is generally safe to combine a standard multivitamin with AREDS2, but care is needed to avoid excessive doses of vitamin E, zinc, or other nutrients.(3,4,8,9,11) Always review your full supplement list with your doctor.

This article is for educational purposes only and reflects current scientific literature at the time of writing.

References

1. National Eye Institute. AREDS/AREDS2 clinical trials: about AREDS and AREDS2. 2025. Available from: https://www.nei.nih.gov/eye-health-information/clinical-trials/age-related-eye-disease-studies-aredsareds2/about-areds-and-areds2
2. National Eye Institute. AREDS2 supplements for age-related macular degeneration. 2021. Available from: https://www.nei.nih.gov/eye-health-information/eye-conditions-and-diseases/age-related-macular-degeneration/nutritional-supplements-age-related-macular-degeneration
3. Gerson LB, Hobbs RP. Vitamins for age-related macular degeneration: an evidence-based analysis. Am Fam Physician. 2012;85(9):888–892. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC3653653
4. BrightFocus Foundation. Vitamins for age-related macular degeneration: do you have the correct formula? 2024. Available from: https://www.brightfocus.org/resource/vitamins-for-age-related-macular-degeneration-do-you-have-the-correct-formula
5. Milton Keynes University Hospital NHS. AREDS 2 trial of vitamins and minerals for macular degeneration. 2026. Available from: https://www.mkuh.nhs.uk/patient-information-leaflet/areds-2-trial-of-vitamins-and-minerals-for-macular-degeneration
6. Retina-Vitreous Surgeons of CNY. AMD and nutritional supplements. 2021. Available from: https://www.rvscny.com/patient-eduction/conditions-we-treat/amd-and-nutritional-supplements
7. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119(10):1417–1436. Available from: https://pubmed.ncbi.nlm.nih.gov/11594942
8. Cleveland Clinic. Can vitamins help slow macular degeneration? 2023. Available from: https://health.clevelandclinic.org/vitamins-for-macular-degeneration
9. Hobbs RP. Nutrient supplementation for age-related macular degeneration. Eye (Lond). 2014;28(6):666–674. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC4329711
10. Chew EY, Clemons TE, Sangiovanni JP, et al. The Age-Related Eye Disease Study 2 (AREDS2): micronutrients in the treatment of AMD. Adv Nutr. 2017;8(1):40–53. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC5227975
11. Bjelakovic G, Nikolova D, Gluud LL, et al. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev. 2012;2012(3):CD007176.
12. Datta S, Cano M, Ebrahimi KB, et al. The impact of oxidative stress and inflammation on RPE degeneration in age-related macular degeneration. Prog Retin Eye Res. 2017;60:201–218. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC7866075
13. Chong EW, Robman LD, Simpson JA, et al. Diet and lifestyle factors for age-related macular degeneration: a systematic review and meta-analysis. Ophthalmology. 2009;116(9):1744–1754. Available from: https://pubmed.ncbi.nlm.nih.gov/19643491
14. Age-Related Eye Disease Study 2 Research Group. Lutein + zeaxanthin and omega‑3 fatty acids for age-related macular degeneration: the AREDS2 randomized clinical trial. JAMA. 2013;309(19):2005–2015. Available from: https://jamanetwork.com/journals/jama/fullarticle/1684847
15. BrightFocus Foundation. New study confirms the efficacy of AREDS2 eye vitamin supplement for slowing age-related macular degeneration. 2025. Available from: https://www.brightfocus.org/resource/new-study-confirms-the-efficacy-of-areds2-eye-vitamin-supplement-for-slowing-age-related-macular-degeneration